1
. The following analyses have found that in addition to mean glycated hemoglobin (HbA 1c ) level, high HbA 1c variability, but not glucose variability, might be associated with increased risks of retinopathy, nephropathy and perhaps neuropathy, in type 1 diabetic patients (Table 1) 2-8 . Although many laboratory and clinical studies suggested that 'short-term' glucose fluctuation, mostly driven by high postprandial blood glucose levels, leading to increased oxidative stress and decreased endothelial function, is responsible for the higher risks of microvascular and cardiovascular outcomes in type 2 diabetic patients 9 , the role of 'longer-term' glucose stability in terms of HbA 1c variability, and the occurrence and progression of diabetic complications among type 1 diabetic patients remains elusive. In a recently published study, Hietala et al. 10 analyzed data from 2,019 type 1 diabetic patients who were enrolled in the Finnish Diabetic Nephropathy (FinnDiane) study. During the average follow up of 5.2 years, they have reconfirmed that high HbA 1c variability was associated with an increased risk of incidence, as well as laser treatment for retinopathy. In the earlier report, they also showed that HbA 1c variability was not only predictive of incident microalbuminuria and progression of renal disease, but also of incident cardiovascular events in type 1 diabetic patients 7 . Of note, patients with high mean HbA 1c values also had high HbA 1c variability. However, patients with low mean HbA 1c value, but high HbA 1c variability, had similar incidence for nephropathy progression as patients with high mean HbA 1c value, but low HbA 1c variability, suggesting an equally important effect of both absolute value and stability in the risk of progression in renal outcome. The significant association between HbA 1c variability, and risks of retinopathy and nephropathy persisted even after taking the number of HbA 1c measurements into consideration.
Why was HbA 1c instability independently associated with a higher chance of laser treatment for retinopathy? The authors emphasized that even short periods of higher HbA 1c could have a sustained effect on worsening of retinopathy despite subsequent improvement in glycemic control 10 . However, because of the inherent limitations in the observational study design, there might be other explanations for the observed association (Figure 1 ). First, because there might be a lag time between worsening of visual . Perhaps, it is these lifestyle and behavior factors (including medication non-adherence) that lead to poor outcomes.
Again, we want to reassure our patients that long-term optimal glycemic control is crucial to reduce retinopathy occurrence and its complications. For healthcare professionals who are involved in the care of diabetic patients, the findings of the study by Hietala et al. 10 
